These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 21651940)
1. Efficient influenza B virus propagation due to deficient interferon-induced antiviral activity in MDCK cells. Frensing T; Seitz C; Heynisch B; Patzina C; Kochs G; Reichl U Vaccine; 2011 Sep; 29(41):7125-9. PubMed ID: 21651940 [TBL] [Abstract][Full Text] [Related]
2. High yields of influenza A virus in Madin-Darby canine kidney cells are promoted by an insufficient interferon-induced antiviral state. Seitz C; Frensing T; Höper D; Kochs G; Reichl U J Gen Virol; 2010 Jul; 91(Pt 7):1754-63. PubMed ID: 20357039 [TBL] [Abstract][Full Text] [Related]
3. Trypsin promotes efficient influenza vaccine production in MDCK cells by interfering with the antiviral host response. Seitz C; Isken B; Heynisch B; Rettkowski M; Frensing T; Reichl U Appl Microbiol Biotechnol; 2012 Jan; 93(2):601-11. PubMed ID: 21915610 [TBL] [Abstract][Full Text] [Related]
5. Production of cell culture (MDCK) derived live attenuated influenza vaccine (LAIV) in a fully disposable platform process. George M; Farooq M; Dang T; Cortes B; Liu J; Maranga L Biotechnol Bioeng; 2010 Aug; 106(6):906-17. PubMed ID: 20589670 [TBL] [Abstract][Full Text] [Related]
6. Comparative study of influenza virus replication in Vero and MDCK cell lines. Youil R; Su Q; Toner TJ; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Kiseleva I; Shaw AR; DiStefano D J Virol Methods; 2004 Sep; 120(1):23-31. PubMed ID: 15234806 [TBL] [Abstract][Full Text] [Related]
7. Adaptation of a Madin-Darby canine kidney cell line to suspension growth in serum-free media and comparison of its ability to produce avian influenza virus to Vero and BHK21 cell lines. van Wielink R; Kant-Eenbergen HC; Harmsen MM; Martens DE; Wijffels RH; Coco-Martin JM J Virol Methods; 2011 Jan; 171(1):53-60. PubMed ID: 20933017 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model. Nerome K; Kumihashi H; Nerome R; Hiromoto Y; Yokota Y; Ueda R; Omoe K; Chiba M Dev Biol Stand; 1999; 98():53-63; discussion 73-4. PubMed ID: 10494959 [TBL] [Abstract][Full Text] [Related]
9. Antigenic alteration of influenza B virus associated with loss of a glycosylation site due to host-cell adaptation. Saito T; Nakaya Y; Suzuki T; Ito R; Saito T; Saito H; Takao S; Sahara K; Odagiri T; Murata T; Usui T; Suzuki Y; Tashiro M J Med Virol; 2004 Oct; 74(2):336-43. PubMed ID: 15332284 [TBL] [Abstract][Full Text] [Related]
10. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs. Govorkova EA; Kodihalli S; Alymova IV; Fanget B; Webster RG Dev Biol Stand; 1999; 98():39-51; discussion 73-4. PubMed ID: 10494958 [TBL] [Abstract][Full Text] [Related]
11. Suitability of MDCK cells grown in a serum-free medium for influenza virus production. Kessler N; Thomas-Roche G; Gérentes L; Aymard M Dev Biol Stand; 1999; 98():13-21; discussion 73-4. PubMed ID: 10494956 [TBL] [Abstract][Full Text] [Related]
12. Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines. Hu AY; Weng TC; Tseng YF; Chen YS; Wu CH; Hsiao S; Chou AH; Chao HJ; Gu A; Wu SC; Chong P; Lee MS Vaccine; 2008 Oct; 26(45):5736-40. PubMed ID: 18761387 [TBL] [Abstract][Full Text] [Related]
13. High titer growth of human and avian influenza viruses in an immortalized chick embryo cell line without the need for exogenous proteases. Smith KA; Colvin CJ; Weber PS; Spatz SJ; Coussens PM Vaccine; 2008 Jul; 26(29-30):3778-82. PubMed ID: 18524432 [TBL] [Abstract][Full Text] [Related]
14. Maturation efficiency of viral glycoproteins in the ER impacts the production of influenza A virus. Ueda M; Yamate M; Du A; Daidoji T; Okuno Y; Ikuta K; Nakaya T Virus Res; 2008 Sep; 136(1-2):91-7. PubMed ID: 18550190 [TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody, but not synthetic peptide, targeting the ectodomain of influenza B virus M2 proton channel has antiviral activity. Wang Y; Xu H; Wu N; Shi H; Wang X; Wang T New Microbiol; 2010 Oct; 33(4):311-7. PubMed ID: 21213589 [TBL] [Abstract][Full Text] [Related]
16. Selection of receptor-binding variants of human influenza A and B viruses in baby hamster kidney cells. Govorkova EA; Matrosovich MN; Tuzikov AB; Bovin NV; Gerdil C; Fanget B; Webster RG Virology; 1999 Sep; 262(1):31-8. PubMed ID: 10489338 [TBL] [Abstract][Full Text] [Related]
17. Cloning and assessment of tumorigenicity and oncogenicity of a Madin-Darby canine kidney (MDCK) cell line for influenza vaccine production. Liu J; Mani S; Schwartz R; Richman L; Tabor DE Vaccine; 2010 Feb; 28(5):1285-93. PubMed ID: 19944150 [TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of cellular proteome alterations in human influenza A virus-infected mammalian cell lines. Vester D; Rapp E; Gade D; Genzel Y; Reichl U Proteomics; 2009 Jun; 9(12):3316-27. PubMed ID: 19504497 [TBL] [Abstract][Full Text] [Related]
19. The N- and C-terminal domains of the NS1 protein of influenza B virus can independently inhibit IRF-3 and beta interferon promoter activation. Donelan NR; Dauber B; Wang X; Basler CF; Wolff T; García-Sastre A J Virol; 2004 Nov; 78(21):11574-82. PubMed ID: 15479798 [TBL] [Abstract][Full Text] [Related]
20. Antiviral effect of strictinin on influenza virus replication. Saha RK; Takahashi T; Kurebayashi Y; Fukushima K; Minami A; Kinbara N; Ichitani M; Sagesaka YM; Suzuki T Antiviral Res; 2010 Oct; 88(1):10-8. PubMed ID: 20615432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]